Objective. To study collagen metabolites in systemic sclerosis (SSc) and their relationship with clinical manifestations of the disease.
Systemic sclerosis (SSc) is characterized by autoimmunreflecting collagen synthesis have been shown to be increased in SSc and to relate to disease activity [7] [8] [9] . ity, microangiopathy and fibrosis of the skin and internal organs. An endothelial lesion is thought to be the This study was undertaken to gain more insight into collagen turnover in early SSc in relation to the involveprimary event in the microangiopathy. An increased production of endothelin-I, an endothelium-derived ment of different organs, with particular emphasis on the balance between synthesis and degradation. We vasoconstricting peptide with reported profibrotic action [1] may constitute a link between the angiopathy and present results supporting the presence of increased catabolism as a marker of the severity of SSc. the fibrosis. Collagen synthesis is increased in SSc fibroblasts [2] [3] [4] whereas the degradation of collagen and the amount of immunologically reacting collagenase Materials and methods are reported to be normal [4] . However, Jimenez et al. [5] found a slight but significant increase in the fraction Forty-eight consecutive patients referred to our departof newly synthesized collagen degraded intracellularly. ment between January 1995 and July 1996 to be evaluFurthermore, Stone et al. [6 ] showed increased levels of ated for systemic sclerosis were included in the study. urinary cross-linked amino acids in SSc patients, thus SSc was confirmed in 36 patients according to the indicating increased degradation of mature collagen and preliminary American College of Rheumatology (ACR) elastin. Serum concentrations of procollagen peptides criteria [10] . Twenty-three of these had limited cutaneous systemic sclerosis ( lcSSc), with skin sclerosis limited to the extremities and face [11] , and 13 had diffuse cutaneous systemic sclerosis (dcSSc) with additional were classified as having suspected systemic sclerosis * Presented in part at the 27th Scandinavian Congress of (suspSSc) with Raynaud's phenomenon and sclerodacRheumatology, Aarhus, Denmark, June 1998 and at the ACR 62nd
tyly, but did not fulfil the ACR criteria. The onset of National Meeting, San Diego, California, USA, November 1998.
ively disease-modifying drug before sampling. Four single-breath method; both were expressed as a percentage. Skin involvement was assessed with a modified patients were under treatment with oral corticosteroids, three of them with ∏5 mg/day and one with 20 mg/day.
Rodnan score determined by standardized palpation of skin areas [15] . It has a theoretical range of 0-72. Nineteen patients were being treated with calcium channel blockers and three with angiotensin converting Statistics enzyme inhibitors. Seven patients were smokers, 14 were ex-smokers and 27 were non-smokers. The controls were
The significance of differences between patients and controls was calculated using the Mann-Whitney test 31 healthy persons. One control was a smoker, 24 were non-smokers, and in six controls smoking habits for unpaired samples and correlation between pairs of parameters with Spearman's r. were unknown. Gender and age of patients and controls are shown in Table 1 .
Aminoterminal type III procollagen peptide
Results
(PIIINP), aminoterminal and carboxyterminal type I procollagen peptides (PINP and PICP) and cross-linked Serum-PIIINP was increased in dcSSc and in lcSSc compared with healthy controls ( Table 1 ). Higher levels carboxyterminal telopeptide of collagen I (ICTP) were determined by radioimmunoassay (Orion Diagnostica, were seen in dcSSc than in lcSSc (P < 0.01). No significant difference in serum PINP was seen between patients Espoo, Finland ).
Capillary abnormalities were analysed quantitatively and controls, whereas a moderate decrease in serum PICP concentration was noted in suspSSc (P < 0.05). by a computer-based method [12] . The pulmonary artery pressure (PAPsyst) was measured in 30/48
The serum ICTP concentration was increased both in dcSSc and in lcSSc compared with controls ( Table 1) . patients by Doppler cardiography, which is a noninvasive technique allowing the pressure to be calculated Patients with dcSSc had higher levels than patients with lcSSc (P < 0.001). No difference in either of the collagen from the velocity of the regurgitant flow through the tricuspid valve [13] . In 1/30 patients, there was no metabolites was found between smoking and nonsmoking patients. regurgitant flow and the pulmonary pressure could not be determined. Glomerular filtration rate (GFR) was A marked correlation was found between serum PIIINP and serum ICTP (r = 0.80, P < 0.01) and determined by iohexol clearance [14] and expressed as the age-adjusted percentage of mean values for healthy between serum PIIINP and PICP concentrations (r = 0.50, P < 0.01). The relationship between serum controls. Pulmonary function was assessed as vital capacity ( VC ), measured by a dry spirometer, and as carbon PICP and ICTP concentrations was less pronounced (r = 0.39, P < 0.05) and no relationship was found monoxide diffusing capacity (DLCO), measured by the Difference between patients and controls: *P < 0.05; ***P < 0.001. ESR = erythrocyte sedimentation rate.
between serum PINP and ICTP or between serum PINP osteoporosis, especially not early in the disease. No and PIIINP concentrations. patient had erosive joint disease in the present study Serum PIIINP and ICTP concentrations both correland only 4/48 had acrolysis on X-ray (not shown). The ated positively with skin score ( Table 2 ) and negatively ICTP levels of these four patients were 6.0, 4.5, 3.0 and with DLCO, but showed no correlation with kidney 3.5 mg/l respectively. Furthermore, the bone-specific function, pulmonary pressure or disease duration. A marker (BSP) was analysed in the dcSSc group with the correlation with the acute-phase reactant orosomucoid highest ICTP levels, and normal values were found (not was found for serum PIIINP and ICTP concentrations.
shown). Increased serum levels of ICTP have also been reported in Crohn's disease [20] and in systemic lupus erythematosus [21] . In none of these studies did the Discussion patients show signs of elevated bone resorption. Garnero Increased serum concentrations of PIIINP, reflecting et al. [22] found no difference between premenopausal increased collagen III production, have been reported women and postmenopausal osteoporotic patients in the previously in SSc in several studies [7, 8, 16 ] , whereas serum concentration of ICTP, in contrast to other bone the serum PICP concentration has been found to be resorption markers, and no effect on ICTP levels of normal [9, 16 ] . In the present study we wanted to antiresorptive therapy with alendronate. Taken together investigate both the synthesis and the degradation of with the observations reported in the present study, this collagen I and III. Patients with suspected SSc not suggests that the antigens measured in the ICTP assay fulfilling the ACR criteria were included as such patients are derived from tissues other than bone affected by SSc. often go on to develop SSc. Eight of 12 fulfilled the Heickendorff et al. [16 ] reported that the serum ACR criteria 2 yr after the initial assessment.
concentrations of PICP and ICTP covaried in systemic Collagen catabolism has been considered previously sclerosis. Their data showed increased ICTP levels in to be normal in SSc [4, 17] . However, Stone et al. [6] SSc patients but they did not report the ICTP values found increased urinary amounts of cross-linked amino separately for the different forms of SSc. Similarly, acids specific for the degradation of mature collagen Autio et al.
[23] reported a correlation between the and elastin, with elevated levels of both hydroxylysylpyrserum concentrations of PICP and ICTP, suggesting idinoline (HP) and lysylpyridinoline (LP). As LP is balanced synthesis and degradation in patients with regarded as originating mainly from bone, they sugdifferent skin diseases, such as eczema, psoriasis and gested resorption of bone in the digits to be the explanatinea. They also reported a low but significant correlation. They also found an increased HP/LP ratio tion between PICP and PIIINP concentrations, indicatcompared with normal, indicating an origin of the HP in a soft tissue. The finding in the present study of an ing coordinated synthesis of collagen I and III in these increased serum ICTP concentration in SSc suggests skin diseases. Such correlations were also noted in the augmented collagen I breakdown, but the tissue origin present study. The highly significant correlation between of the metabolite is unclear. The majority of collagen I ICTP and PIIINP concentrations is more difficult to in the body is present in bone (50-70%), and as bone explain, but could indicate that the increased PIIINP is a metabolically more active tissue than soft tissue, concentration also reflects degradation of tissue type III ICTP has been regarded as a marker preferentially pN-collagen, as has been reported after streptokinase reflecting bone collagen degradation [18] Significance of the correlation: *P < 0.05; **P < 0.01. ESR = erythrocyte sedimentation rate.
of this metabolite.
to plasma concentration of von Willebrand factor. Ann
